1608. Efficacy of Ceftolozane/Tazobactam for Multidrug-Resistant Gram-Negative Infections in Multiple Urban Hospitals

BACKGROUND: Ceftolozane/tazobactam (C/T) is a novel cephalosporin/beta-lactamase inhibitor combination developed for use against multidrug-resistant (MDR) Gram-negative infections, particularly Pseudomonas aeruginosa (PA). C/T is approved for complicated urinary tract and intraabdominal infections a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera, Nicolo, Tran, Truc T, Carlson, Travis J, Alnezary, Faris, Miller, William R, Dinh, An Q, Hanson, Blake, Munita, Jose, Shelburne, Samuel A, Aitken, Samuel L, Garey, Kevin W, Puzniak, Laura A, Arias, Cesar A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777747/
http://dx.doi.org/10.1093/ofid/ofaa439.1788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777747/
http://dx.doi.org/10.1093/ofid/ofaa439.1788

Ejemplares similares